Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 758338305 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Era Regenerative Medicine Ltd
13D/A
Amendment 2
|
57.8% |
6/11/2025
Event 6/4/2025
|
|
| Era Regenerative Medicine Ltd | 57.8% | ||
| D&D Source of Life Holding Ltd. | 57.8% | ||
|
Era Regenerative Medicine Ltd
13D/A
Amendment 1
|
59.5% |
5/2/2025
Event 4/16/2025
|
|
| Era Regenerative Medicine Ltd | 59.5% | ||
| D&D Source of Life Holding Ltd. | 59.5% | ||
|
Era Regenerative Medicine Ltd
13D
|
59.5% |
2/28/2025
Event 12/31/2024
|
|
| Era Regenerative Medicine Ltd | 59.5% | ||
| D&D Source of Life Holding Ltd. | 59.5% | ||
|
Whitebox Advisors LLC
13G/A
Amendment 4
|
0.8% |
2/14/2025
Event 12/31/2024
|
|
| Whitebox Advisors LLC | 0.8% | ||
| Whitebox General Partner LLC | 0.8% | ||
| Whitebox Multi-Strategy Partners, LP | 0.5% | ||
|
Shufen Deng
13D/A
Amendment 4
|
59.5% |
1/31/2025
Event 12/30/2024
|
|
| D&D Source of Life Holding Ltd. | 59.5% | ||
| Shufen Deng | 0% |